Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 07.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensat |
| 30.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensat |
| 09.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensat |
Stammdaten
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Unternehmen & Branche
| Name | INTERNATIONAL FLAVORS & FRAGRANCES INC |
|---|---|
| Ticker | IFF |
| CIK | 0000051253 |
| Boerse | US |
| Sektor | Basic Materials |
| Industrie | Chemicals - Specialty |
| SIC | 2860 · Industrial Organic Chemicals |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 17,95 Mrd. USD |
| Beta | 1,03 |
| Dividendenrendite | 1,60 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 10,890,000,000 | -1.41 | 25,539,000,000 | 14,154,000,000 | |
| 2025-09-30 | 10-Q | 2,694,000,000 | 40,000,000 | 0.16 | 25,768,000,000 | 14,241,000,000 |
| 2025-06-30 | 10-K | 2,764,000,000 | ||||
| 2025-06-30 | 10-Q | 2,764,000,000 | 612,000,000 | 2.38 | 26,121,000,000 | 14,404,000,000 |
| 2025-03-31 | 10-Q | 2,843,000,000 | -1,018,000,000 | -3.98 | 28,265,000,000 | 13,177,000,000 |
| 2024-12-31 | 10-K | 2,771,000,000 | 1.04 | 28,723,000,000 | 13,834,000,000 | |
| 2024-09-30 | 10-K | 2,925,000,000 | ||||
| 2024-09-30 | 10-Q | 2,925,000,000 | 58,000,000 | 0.23 | 29,928,000,000 | 14,775,000,000 |
| 2024-06-30 | 10-Q | 2,889,000,000 | 170,000,000 | 0.66 | 29,543,000,000 | 14,254,000,000 |
| 2024-06-30 | 10-K | 5,788,000,000 | ||||
| 2024-03-31 | 10-Q | 2,899,000,000 | 60,000,000 | 0.23 | 30,642,000,000 | 14,291,000,000 |
| 2023-12-31 | 10-K | 11,479,000,000 | -10.14 | 30,978,000,000 | 14,611,000,000 | |
| 2023-09-30 | 10-Q | 2,820,000,000 | 25,000,000 | 0.10 | 33,395,000,000 | 16,978,000,000 |
| 2023-06-30 | 10-Q | 2,929,000,000 | 27,000,000 | 0.11 | 34,459,000,000 | 17,623,000,000 |
| 2023-03-31 | 10-Q | 3,027,000,000 | -9,000,000 | -0.04 | 35,470,000,000 | 17,758,000,000 |
| 2022-12-31 | 10-K | 12,440,000,000 | -7.32 | 35,522,000,000 | 17,655,000,000 | |
| 2022-09-30 | 10-Q | 3,063,000,000 | -2,197,000,000 | -8.60 | 34,537,000,000 | 16,887,000,000 |
| 2022-06-30 | 10-Q | 3,307,000,000 | 107,000,000 | 0.43 | 39,304,000,000 | 20,260,000,000 |
| 2022-03-31 | 10-Q | 3,226,000,000 | 244,000,000 | 0.96 | 39,747,000,000 | 20,933,000,000 |
| 2021-12-31 | 10-K | 11,656,000,000 | 1.10 | 39,658,000,000 | 21,082,000,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Fyrwald J Erik | Director, Officer, Chief Executive Officer | Open Market Purchase | 13,360 | 69.85 | 933,224.06 | +125,5% | |
| 2026-03-12 | FRIBOURG PAUL J | Director | Open Market Purchase | 142,000 | 70.13 | 9,957,963.00 | +1339,3% | |
| 2026-03-12 | Fyrwald J Erik | Director, Officer, Chief Executive Officer | Open Market Purchase | 900 | 68.87 | 61,980.03 | +8,3% | |
| 2026-03-12 | FRIBOURG PAUL J | Director | Open Market Purchase | 14,200 | 70.07 | 995,015.30 | +133,8% | |
| 2026-03-06 | FRIBOURG PAUL J | Director | Open Market Purchase | 3 | 73.93 | 221.79 | 0,0% | |
| 2026-02-09 | FRIBOURG PAUL J | Director | Open Market Purchase | 146 | 74.63 | 10,895.98 | +1,5% | |
| 2025-12-15 | FRIBOURG PAUL J | Director | Open Market Sale | -3 | 63.35 | -190.05 | 0,0% | |
| 2025-12-12 | Landsman Stephen N | Officer, EVP, General Counsel | Open Market Purchase | 3,100 | 63.48 | 196,788.00 | +26,5% | |
| 2025-12-10 | FRIBOURG PAUL J | Director | Open Market Sale | -25 | 65.27 | -1,631.75 | -0,2% | |
| 2025-11-18 | FRIBOURG PAUL J | Director | Open Market Sale | -187 | 65.42 | -12,233.54 | -1,6% | |
| 2025-10-30 | FRIBOURG PAUL J | Director | Open Market Purchase | 39 | 63.64 | 2,481.96 | +0,3% | |
| 2025-09-29 | FRIBOURG PAUL J | Director | Open Market Sale | -7 | 60.87 | -426.09 | -0,1% | |
| 2025-08-27 | FRIBOURG PAUL J | Director | Open Market Purchase | 71 | 66.91 | 4,750.61 | +0,6% | |
| 2025-08-07 | FRIBOURG PAUL J | Director | Open Market Purchase | 15,450 | 64.80 | 1,001,183.18 | +134,7% | |
| 2025-08-07 | Fyrwald J Erik | Director, Officer, Chief Executive Officer | Open Market Purchase | 15,300 | 64.95 | 993,713.58 | +133,7% | |
| 2025-05-22 | O'Byrne Kevin | Director | Open Market Purchase | 4,500 | 76.05 | 342,240.30 | +46,0% | |
| 2025-05-19 | Yildiz Beril | Officer, CAO, SVP & Controller | Open Market Sale | -2,400 | 77.34 | -185,604.00 | -25,0% | |
| 2025-05-19 | Landsman Stephen N | Officer, EVP, General Counsel | Open Market Purchase | 2,000 | 77.58 | 155,155.60 | +20,9% | |
| 2025-05-19 | Landsman Stephen N | Officer, EVP, General Counsel | Open Market Purchase | 10,000 | 77.22 | 772,200.00 | +103,9% | |
| 2025-05-19 | Palau Hernandez Margarita | Director | Open Market Purchase | 850 | 77.42 | 65,807.00 | +8,9% | |
| 2025-05-15 | Khan Mehmood | Director | Open Market Purchase | 300 | 75.32 | 22,596.00 | +3,0% | |
| 2025-05-15 | Khan Mehmood | Director | Open Market Purchase | 3,700 | 75.33 | 278,717.67 | +37,5% | |
| 2025-05-09 | Fyrwald J Erik | Director, Officer, Chief Executive Officer | Open Market Purchase | 24,300 | 73.97 | 1,797,456.42 | +241,8% | |
| 2025-05-08 | Fyrwald J Erik | Director, Officer, Chief Executive Officer | Open Market Purchase | 700 | 74.00 | 51,797.13 | +7,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.